Tower Research Capital LLC (Trc) Cytosorbents Corp Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Cytosorbents Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,503 shares of CTSO stock, worth $4,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,503

Previous 2,095 162.67%

Holding current value

$4,732

Previous $1,000 400.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.89 - $1.3 $3,033 - $4,430	3,408 Added 162.67%	5,503 $5,000
Q4 2024 Feb 13, 2025	SELL	$0.74 - $1.35 $655 - $1,196	-886 Reduced 29.72%	2,095 $1,000
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.55 $13,102 - $29,012	-18,718 Reduced 86.26%	2,981 $4,000
Q2 2024 Aug 13, 2024	BUY	$0.7 - $1.01 $9,572 - $13,811	13,675 Added 170.43%	21,699 $15,000
Q1 2024 May 15, 2024	BUY	$0.86 - $1.07 $1,607 - $1,999	1,869 Added 30.37%	8,024 $7,000
Q4 2023 Feb 13, 2024	BUY	$1.08 - $1.94 $5,780 - $10,382	5,352 Added 666.5%	6,155 $6,000
Q3 2023 Nov 14, 2023	BUY	$1.86 - $4.03 $1,222 - $2,647	657 Added 450.0%	803 $1,000
Q2 2023 Aug 14, 2023	BUY	$2.37 - $3.65 $346 - $532	146 New	146 $0
Q3 2022 Nov 10, 2022	BUY	$1.2 - $2.46 $1,149 - $2,356	958 New	958 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $12,019 - $21,989	-6,829 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.88 - $4.23 $81,144 - $119,180	-28,175 Reduced 80.49%	6,829 $22,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $26,555 - $53,177	6,557 Added 23.05%	35,004 $146,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $2,289 - $3,175	-327 Reduced 1.14%	28,447 $231,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $183,434 - $228,868	24,296 Added 542.56%	28,774 $218,000
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $897 - $1,251	-109 Reduced 2.38%	4,478 $39,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $249,642 - $293,044	-32,633 Reduced 87.68%	4,587 $36,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $225,330 - $352,823	30,574 Added 460.04%	37,220 $297,000
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $41,736 - $70,381	6,646 New	6,646 $66,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $14,974 - $30,703	-3,972 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.61 - $5.22 $6,158 - $8,905	1,706 Added 75.29%	3,972 $15,000
Q3 2019 Nov 05, 2019	SELL	$4.33 - $7.63 $2,875 - $5,066	-664 Reduced 22.66%	2,266 $11,000
Q2 2019 Aug 13, 2019	SELL	$5.92 - $7.78 $14,882 - $19,558	-2,514 Reduced 46.18%	2,930 $20,000
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $33,083 - $41,524	4,851 Added 818.04%	5,444 $41,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $4,180 - $7,495	593 New	593 $5,000
Q2 2018 Aug 15, 2018	SELL	$6.9 - $12.35 $7,396 - $13,239	-1,072 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $1,925 - $2,410	294 Added 37.79%	1,072 $8,000
Q4 2017 Feb 09, 2018	BUY	$5.9 - $7.05 $4,590 - $5,484	778	778 $5,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cytosorbents Corp Transaction History